We are live on
!
Find out more
Syndax Pharmaceuticals
SNDX
SNDX
72 hedge funds and large institutions have $244M invested in Syndax Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
62% more capital invested
Capital invested by funds: $150M → $244M (+$94M)
60% more call options, than puts
Call options by funds: $635K | Put options by funds: $397K
47% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 19
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.88% less ownership
Funds ownership: 70.41% → 69.53% (-0.88%)
10% less funds holding
Funds holding: 80 → 72 (-8)
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Holders
72
Holders Change
-8
Holders Change %
-10%
% of All Funds
1.65%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
28
Reduced
19
Closed
15
Calls
$635K
Puts
$397K
Net Calls
+$238K
Net Calls Change
+$247K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.18M |
| 2 |
6CM
683 Capital Management
New York
|
+$3.01M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.36M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.84M |
| 5 |
BlackRock
New York
|
+$1.35M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$4.65M |
| 2 |
Millennium Management
New York
|
-$1.86M |
| 3 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
-$1.79M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.51M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$613K |
